Get the Stockscreener App
1.37
9.60%
0.12
Cibus Inc stock is traded at $1.37, with a volume of 273.46K.
It is up +9.60% in the last 24 hours and down -20.35% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.25
Open:
$1.27
24h Volume:
273.46K
Relative Volume:
0.65
Market Cap:
$66.27M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.0679
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
-2.84%
1M Performance:
-20.35%
6M Performance:
-34.13%
1Y Performance:
-80.87%
1-Day Range:
$1.26
$1.39
1-Week Range:
$1.22
$1.4396
52-Week Range:
$1.22
$7.98
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.37 | 73.03M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Traders Consider Averaging Down in Cibus Inc.Weekly Market Summary & Consistent Profit Trading Strategies - thegnnews.com
Will Cibus Inc. Benefit From Sector TailwindsJuly 2025 Setups & Daily Profit Maximizing Trade Tips - beatles.ru
Backtesting results for Cibus Inc. trading strategiesDollar Strength & Fast Moving Stock Trade Plans - Newser
Can Cibus Inc. hit a new high this monthWeekly Stock Summary & Verified Momentum Stock Alerts - Newser
Will Cibus Inc. bounce back from current supportQuarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser
When is the best time to exit Cibus Inc.July 2025 Summary & Low Drawdown Trading Strategies - Newser
Is a relief rally coming for Cibus Inc. holdersEarnings Overview Summary & Fast Exit and Entry Trade Guides - Newser
How high can Cibus Inc. stock goPortfolio Performance Report & High Return Trade Opportunity Guides - Newser
Cibus targets $200M annual royalty revenue from rice traits as regulatory landscape evolves - MSN
Using data filters to optimize entry into Cibus Inc.July 2025 Analyst Calls & AI Based Buy and Sell Signals - Newser
Cibus Reports Disappointing Q2 Earnings Amid Weak Market Reaction - AInvest
Cibus, Inc. (NASDAQ:CBUS) Q2 2025 Earnings Call Transcript - MSN
Signal strength of Cibus Inc. stock in tech scannersJuly 2025 Update & High Yield Stock Recommendations - Newser
Price Channel Expanding on Cibus Inc.’s ChartJuly 2025 Sector Moves & Long-Term Safe Return Strategies - newsyoung.net
Cibus Reports Q2 2025 Earnings: A Deep Loss Amid Weak Revenue and High Operating Costs - AInvest
Combining machine learning predictions for Cibus Inc.2025 Volume Leaders & Daily Risk Controlled Trade Plans - Newser
Cibus Inc. Forms Double Bottom Pattern — Eyes on Breakout2025 Year in Review & Reliable Entry Point Alerts - 선데이타임즈
Using AI based signals to follow Cibus Inc.Dividend Hike & Weekly Breakout Watchlists - Newser
Smart tools for monitoring Cibus Inc.’s price actionEarnings Performance Report & Reliable Breakout Forecasts - Newser
Key resistance and support levels for Cibus Inc.Treasury Yields & Weekly Hot Stock Watchlists - Newser
Leading vs lagging indicators on Cibus Inc. performanceJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Short Term Trend Reversal in Cibus Inc. PossibleWeekly Profit Analysis & Intraday High Probability Alerts - classian.co.kr
Cibus Second Quarter 2025 Earnings: Misses Expectations - uk.finance.yahoo.com
Should you wait for a breakout in Cibus Inc.2025 Short Interest & Consistent Profit Alerts - Newser
How moving averages guide Cibus Inc. tradingJuly 2025 Movers & Breakout Confirmation Trade Signals - Newser
Tools to monitor Cibus Inc. recovery probability2025 Market Trends & Verified Trade Idea Suggestions - Newser
What data driven models say about Cibus Inc.’s futureWeekly Market Outlook & Momentum Based Trading Ideas - Newser
Cibus, Inc. Reports Q2 2025 Financial Results - iGrow News
Cibus Inc. shares fall 1.36% premarket after reporting second quarter financial results. - AInvest
Cibus Inc (CBUS) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial Outlook - Yahoo Finance
Cibus (CBUS): Assessing the Path to Commercialization and Shareholder Value Realization - AInvest
Cibus' Q2 2025: Navigating Contradictions in EU Regulations and Biofragrance Revenue - AInvest
Cibus Q2 2025 Earnings Call Transcript - MarketBeat
Cibus: Q2 Earnings Snapshot - Chron
Transcript : Cibus, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Earnings call transcript: Cibus Q2 2025 sees stock rise 3.52% post-call - Investing.com Nigeria
Earnings call transcript: Cibus Q2 2025 sees stock rise 3.52% post-call By Investing.com - Investing.com South Africa
Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Cibus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Regression Model Predicts Rangebound Movement in Cibus Inc.Recession Risk & Technical Buy Zone Confirmations - 선데이타임즈
Cibus: Navigating Short-Term Losses to Unlock Long-Term Value in Agricultural Biotechnology - AInvest
Cibus, Inc. SEC 10-Q Report - TradingView
Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025 - MarketScreener
Gene Editing Pioneer Cibus Streamlines Operations, Secures Path to 2027 Rice Trait Launch - Stock Titan
Cibus to Report Q2 2025 Financial Results and Host Conference Call on August 14, 2025 - AInvest
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cibus Inc Stock (CBUS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Prante Gerhard | Director |
Feb 24 '25 |
Sale |
2.07 |
1,150 |
2,380 |
8,857 |
| Prante Gerhard | Director |
Feb 21 '25 |
Sale |
2.20 |
1,150 |
2,530 |
10,007 |
| Prante Gerhard | Director |
Feb 20 '25 |
Sale |
2.35 |
1,150 |
2,702 |
11,157 |
| Prante Gerhard | Director |
Feb 19 '25 |
Sale |
2.58 |
1,150 |
2,967 |
12,307 |
| Prante Gerhard | Director |
Feb 18 '25 |
Sale |
2.52 |
2,300 |
5,796 |
13,457 |
| Prante Gerhard | Director |
Feb 14 '25 |
Sale |
2.60 |
1,150 |
2,990 |
15,757 |
| Prante Gerhard | Director |
Feb 13 '25 |
Sale |
2.53 |
1,150 |
2,910 |
16,907 |
| Prante Gerhard | Director |
Feb 12 '25 |
Sale |
2.45 |
1,150 |
2,818 |
18,057 |
| Prante Gerhard | Director |
Feb 11 '25 |
Sale |
2.48 |
1,150 |
2,852 |
19,207 |
| Prante Gerhard | Director |
Feb 10 '25 |
Sale |
2.52 |
1,150 |
2,898 |
20,357 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):